Therefore, we used the Sahlgrenska Academy Study on Ischemic Stroke (SAHLSIS) cohort to investigate whether s-IGFBP-1 levels in the acute phase or 3 months after stroke are associated with outcome after stroke in terms of functional independence and mortality. This evidence concerns the gene IGFBP1 and ischemic stroke.